Mr Thomas Bühler Heinrich, Director Sales Africa, Middle East & Asia, Optima Pharma GmbH
Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad
Author
Mr Vishal Wagh, Director, Adam Fabriwerk
Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad
Panel Discussion: The next decade of injectables: Science, scale and new therapies
Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad
Dr Raches Ella, CDO, Bharat Biotech
Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad
CDSCO clarifies injectables cannot be marketed as cosmetics, warns against misleading claims
Central Drugs Standard Control Organisation (CDSCO) has issued a public notice clarifying that cosmetic products cannot be…
Platinum Industries collaborates with Dr Abhigyan Upadhyay to lead new enterprise, Rivadu…
Platinum Industries, an innovation-driven specialty chemicals company announced its strategic entry into the life sciences sector,…
Venus Remedies receives Saudi FDA approval for Plerixafor
Venus Remedies, among the world's ten largest fixed-dosage injectable manufacturers, has received Marketing Authorization from the…
India’s first CAR T-Cell therapy shows durable results
In a major milestone in Indian oncology care, Immuneel Therapeutics’ Made-In-India CAR T-cell therapy has delivered the country’s…
Shaily announces approval, launch of customer combo product with ShailyPen Neo Device Technology
USFDA Tentative Approval, Health Canada Notice of Compliance, and India CDSCO approval have been secured for a customer's generic…
Dr. Reddy’s Laboratories launches oral semaglutide biosimilar ‘Obeda’ tablets in India
Dr. Reddy’s Laboratories, a global pharmaceutical company, announced the launch of its oral semaglutide biosimilar, indicated for…